Shree Ganesh Remedies rises on getting FDA license to manufacture products at Ankleshwar facility
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Shree Ganesh Remedies is currently trading at Rs. 394.80, up by 2.75 points or 0.70% from its previous closing of Rs. 392.05 on the BSE.
The scrip opened at Rs. 399.00 and has touched a high and low of Rs. 399.00 and Rs. 388.20 respectively. So far 3381 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 475.35 on 03-Jul-2023 and a 52 week low of Rs. 211.69 on 20-Oct-2022.
Last one week high and low of the scrip stood at Rs. 420.00 and Rs. 384.00 respectively. The current market cap of the company is Rs. 507.21 crore.
The promoters holding in the company stood at 69.33%, while Non-Institutions held 30.67% stake in the company.
Food & Drugs Control Administration Gujarat State has granted FDA License to manufacture various products and drugs at the Shree Ganesh Remedies' manufacturing unit at Ankleshwar, Gujarat, India acknowledged as Good Manufacturing Practice (GMP).
Shree Ganesh Remedies is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry.
